333 related articles for article (PubMed ID: 21992534)
1. Clinical outcomes and changes in aqueous vascular endothelial growth factor levels after intravitreal bevacizumab for iris neovascularization and neovascular glaucoma: a retrospective two-dose comparative study.
Sasamoto Y; Oshima Y; Miki A; Wakabayashi T; Song D; Matsushita K; Hamasaki T; Nishida K
J Ocul Pharmacol Ther; 2012 Feb; 28(1):41-8. PubMed ID: 21992534
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
[TBL] [Abstract][Full Text] [Related]
3. Levels of erythropoietin and vascular endothelial growth factor in surgery-required advanced neovascular glaucoma eyes before and after intravitreal injection of bevacizumab.
Zhou M; Chen S; Wang W; Huang W; Cheng B; Ding X; Zhang X
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):3874-9. PubMed ID: 23674760
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial.
Yazdani S; Hendi K; Pakravan M; Mahdavi M; Yaseri M
J Glaucoma; 2009; 18(8):632-7. PubMed ID: 19826393
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy.
Eid TM; Radwan A; el-Manawy W; el-Hawary I
Can J Ophthalmol; 2009 Aug; 44(4):451-6. PubMed ID: 19606170
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing Ahmed glaucoma valve implantation: 2-year follow-up.
Arcieri ES; Paula JS; Jorge R; Barella KA; Arcieri RS; Secches DJ; Costa VP
Acta Ophthalmol; 2015 Feb; 93(1):e1-6. PubMed ID: 24989855
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series.
Kotecha A; Spratt A; Ogunbowale L; dell'Omo R; Kulkarni A; Bunce C; Franks WA
Arch Ophthalmol; 2011 Feb; 129(2):145-50. PubMed ID: 21320957
[TBL] [Abstract][Full Text] [Related]
8. Intracameral bevacizumab (Avastin) for neovascular glaucoma: a pilot study in 6 patients.
Duch S; Buchacra O; Milla E; Andreu D; Tellez J
J Glaucoma; 2009 Feb; 18(2):140-3. PubMed ID: 19225351
[TBL] [Abstract][Full Text] [Related]
9. Effect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patients.
Sugimoto Y; Mochizuki H; Okumichi H; Takumida M; Takamatsu M; Kawamata S; Kiuchi Y
Graefes Arch Clin Exp Ophthalmol; 2010 Nov; 248(11):1601-9. PubMed ID: 20524132
[TBL] [Abstract][Full Text] [Related]
10. Topical bevacizumab for neovascular glaucoma: a pilot study.
Waisbourd M; Shemesh G; Kurtz S; Rachmiel R; Moisseiev E; Zayit-Soudri S; Loewenstein A; Barequet I
Pharmacology; 2014; 93(3-4):108-12. PubMed ID: 24556733
[TBL] [Abstract][Full Text] [Related]
11. Concentration of vascular endothelial growth factor after intracameral bevacizumab injection in eyes with neovascular glaucoma.
Lim TH; Bae SH; Cho YJ; Lee JH; Kim HK; Sohn YH
Korean J Ophthalmol; 2009 Sep; 23(3):188-92. PubMed ID: 19794946
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.
Moraczewski AL; Lee RK; Palmberg PF; Rosenfeld PJ; Feuer WJ
Br J Ophthalmol; 2009 May; 93(5):589-93. PubMed ID: 19074917
[TBL] [Abstract][Full Text] [Related]
13. Short-term effect of intravitreal ranibizumab on intraocular concentrations of vascular endothelial growth factor-A and pigment epithelium-derived factor in neovascular glaucoma.
Wang JW; Zhou MW; Zhang X; Huang WB; Gao XB; Wang W; Chen S; Zhang XY; Ding XY; Jonas JB
Clin Exp Ophthalmol; 2015 Jul; 43(5):415-21. PubMed ID: 25488632
[TBL] [Abstract][Full Text] [Related]
14. Surgical results of Ahmed valve implantation with intraoperative bevacizumab injection in patients with neovascular glaucoma.
Ma KT; Yang JY; Kim JH; Kim NR; Hong S; Lee ES; Seong GJ; Kim CY
J Glaucoma; 2012; 21(5):331-6. PubMed ID: 21673594
[TBL] [Abstract][Full Text] [Related]
15. Combined intravitreal bevacizumab and trabeculectomy with mitomycin C versus trabeculectomy with mitomycin C alone for neovascular glaucoma.
Takihara Y; Inatani M; Kawaji T; Fukushima M; Iwao K; Iwao M; Tanihara H
J Glaucoma; 2011 Mar; 20(3):196-201. PubMed ID: 20440215
[TBL] [Abstract][Full Text] [Related]
16. Anti-VEGF intravitreal bevacizumab for radiation-associated neovascular glaucoma.
Nagendran ST; Finger PT
Ophthalmic Surg Lasers Imaging Retina; 2015 Feb; 46(2):201-7. PubMed ID: 25707045
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive with versus without intravitreal bevacizumab injection before Ahmed glaucoma valve implantation in the treatment of neovascular glaucoma.
Zhou MW; Wang W; Huang WB; Chen SD; Li XY; Gao XB; Zhang XL
Chin Med J (Engl); 2013; 126(8):1412-7. PubMed ID: 23595369
[TBL] [Abstract][Full Text] [Related]
18. Effect of intravitreal bevacizumab injection before Ahmed glaucoma valve implantation in neovascular glaucoma.
Sevim MS; Buttanri IB; Kugu S; Serin D; Sevim S
Ophthalmologica; 2013; 229(2):94-100. PubMed ID: 23364308
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous increase in multiple proinflammatory cytokines in the aqueous humor in neovascular glaucoma with and without intravitreal bevacizumab injection.
Ohira S; Inoue T; Shobayashi K; Iwao K; Fukushima M; Tanihara H
Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):3541-8. PubMed ID: 26030108
[TBL] [Abstract][Full Text] [Related]
20. Aqueous humor levels of vascular endothelial growth factor before and after intravitreal bevacizumab in type 3 versus type 1 and 2 neovascularization. A prospective, case-control study.
dell'Omo R; Cassetta M; dell'Omo E; di Salvatore A; Hughes JM; Aceto F; Porcellini A; Costagliola C
Am J Ophthalmol; 2012 Jan; 153(1):155-61.e2. PubMed ID: 21861975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
